Virtual Medicinal Product (VMP)
-
Progesterone 100mg/2ml solution for injection ampoules
Name Details
|
Current Name
Progesterone 100mg/2ml solution for injection ampoules
|
Start Date
28-06-2004
|
End Date
|
|
Previous Name
Progesterone 50mg/ml injection 2ml ampoules
|
Start Date
07-04-2003
|
End Date
27-06-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular-deep
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G03DA04
| BNF |
|
Current BNF
06040102
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
06040102
|
Start Date
24-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 36022011000001106 |
29-10-2018 |
|
| 325625003 |
07-04-2003 |
28-10-2018 |
VMP Ingredients
VMP ingredients table
| Progesterone |
Based on Ingredient Substance |
|
50 mg |
1 ml |
Name
Progesterone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Progesterone
-
VMP
(Current) Progesterone 100mg/2ml solution for ...
Virtual Medicinal Product Pack (VMPP) Information